Published in Am J Vet Res on October 01, 1994
Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector. Anal Chem (1968) 1.80
Electrophysiological indicator of awakening from coma. Lancet (1993) 1.61
Clinical and biochemical comparison of clorazepate and diazepam. Psychol Med (1974) 1.46
Influence of posture on plasma nitroglycerin. Br J Clin Pharmacol (1985) 1.45
Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect. Proc R Soc Med (1971) 1.43
A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med (1992) 1.42
Factors affecting chlorpromazine plasma levels in psychiatric patients. Arch Gen Psychiatry (1970) 1.42
Uptake of disodium cromoglycate in obstructive airways disease. Clin Allergy (1973) 1.38
Natural history and course of acquired lactic acidosis in adults. DCA-Lactic Acidosis Study Group. Am J Med (1994) 1.38
Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Clin Pharmacol Ther (1973) 1.36
Plasma protein binding of chlorpromazine. J Pharm Pharmacol (1970) 1.30
Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patients. Life Sci (1968) 1.29
Studies of delayed-action medication. V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine. Clin Pharmacol Ther (1970) 1.28
The physiological disposition of chlorpromazine in the rat and dog. Proc Soc Exp Biol Med (1970) 1.28
Plasma concentrations in the monkey (Macaca mulatta) of six related benzodiazepines after intraperitoneal injection [proceedings]. Br J Pharmacol (1976) 1.24
Treatment of lactic acidosis with dichloroacetate. N Engl J Med (1983) 1.11
Penetration of cefaclor into the interstitial space fluid of skeletal muscle and lung tissue in rats. Pharm Res (2001) 1.02
Plasma-trifluoperazine concentrations during high dose therapy. Lancet (1981) 1.01
Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate. Clin Pharmacol Ther (1985) 1.00
Preparation and stability of indomethacin solutions. Can J Physiol Pharmacol (1982) 1.00
Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis. Clin Sci (1972) 0.99
Destruction of chlorpromazine during absorption in the rat in vivo and in vitro. Br J Pharmacol (1971) 0.99
Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle. J Vet Pharmacol Ther (1998) 0.94
Effect of acepromazine on the anesthetic requirement of halothane in the dog. Am J Vet Res (1986) 0.94
Chlorpromazine plasma levels and effects. Arch Gen Psychiatry (1970) 0.93
Anesthetic machine explosion. Anesthesiology (1982) 0.92
Amikacin sulfate in mares: pharmacokinetics and body fluid and endometrial concentrations after repeated intramuscular administration. Am J Vet Res (1984) 0.92
Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment. Lancet (1984) 0.92
Disposition of glutethimide in man. Clin Pharmacol Ther (1971) 0.92
Effect of dose and ointment application technique on nitroglycerin plasma concentrations. Pharmacotherapy (1983) 0.91
Event-related potentials--neurophysiological tools for predicting emergence and early outcome from traumatic coma. Intensive Care Med (1996) 0.91
Methods for study of fluphenazine kinetics in man. J Pharm Pharmacol (1976) 0.91
Interaction of glutethimide and phenobarbitone with ethanol in man. J Pharm Pharmacol (1972) 0.91
Letter: A note on the analysis of disodium cromoglycate (Intal) in human urine. J Pharm Pharmacol (1973) 0.90
Destruction of chlorpromazine during absorption by rat intestine in vitro. Br J Pharmacol (1970) 0.89
Pharmacokinetics of closely related benzodiazepines. Br J Clin Pharmacol (1979) 0.88
Chronic toxicity of dichloroacetate: possible relation to thiamine deficiency in rats. Fundam Appl Toxicol (1990) 0.88
The physiological disposition of 2(2,6-dichloroanilino)-2-imidazoline (St-155). Biochem Pharmacol (1969) 0.88
Acute tolerance to a sedative in man. Br J Pharmacol (1970) 0.88
Double-blind trial of fluphenazine decanoate. Lancet (1972) 0.88
Theoretical changes in drug distribution resulting from changes in binding to plasma proteins and to tissues. J Pharm Pharmacol (1970) 0.87
Proceedings: Clinical pharmacology of chlorpromazine. Br J Pharmacol (1972) 0.87
Behavioural and pharmacokinetic studies in the monkey (Macaca mulatta) with diazepam, nordiazepam and related 1,4-benzodiazepines. Br J Pharmacol (1977) 0.87
Plasma-fluphenazine concentrations after injection of long-acting esters. Lancet (1978) 0.86
Relative bioavailability of trimeprazine tablets investigated in man using HPLC with electrochemical detection. J Pharm Pharmacol (1986) 0.85
Body composition of the horse. Equine Vet J (1979) 0.85
Clinical effects and metabolism of diazepam in patients with chronic liver disease. Clin Sci (Lond) (1982) 0.84
Improved EMIT analysis for lidocaine. Clin Chem (1985) 0.84
Pharmacokinetics of dichloroacetate in adult patients with lactic acidosis. J Clin Pharmacol (1997) 0.84
Bratton-Marshall and liquid-chromatographic methods compared for determination of sulfamethazine acetylator status. Clin Chem (1981) 0.83
Concentration-effect relationships with major and minor tranquilizers. Clin Pharmacol Ther (1974) 0.83
Long-acting phenothiazines in schizophrenia. Br Med J (1971) 0.83
The form and distribution of auditory evoked potentials and CNVs when stimuli and responses are lateralized. Prog Brain Res (1980) 0.83
Trials of lithium, chlorpromazine and amitriptyline in schizoaffective patients. Br J Psychiatry (1978) 0.83
Plasma and erythrocyte cholinesterase values for the common long-nosed armadillo, Dasypus novemcinctus. J Wildl Dis (1989) 0.82
Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man. Br J Clin Pharmacol (1979) 0.82
Evaluation of a brain-targeting zidovudine chemical delivery system in dogs. Antimicrob Agents Chemother (1997) 0.82
Fatal interaction between thiamylal sodium and a proprietary antidiarrheal preparation in the dog. J Am Vet Med Assoc (1983) 0.82
Quantitative electroencephalographic evaluation of non-fatal and fatal traumatic coma. Electroencephalogr Clin Neurophysiol (1998) 0.82
Analysis of plasma trifluoperazine by gas chromatography and selected ion monitoring. J Chromatogr (1982) 0.81
Anaphylactic and reagin-like antibody in rats infected with Toxocara canis larvae. J Parasitol (1967) 0.81
Propofol in rabbits. 2. Long-term anesthesia. Lab Anim Sci (1993) 0.81
Serum lidocaine concentrations following application to the oropharynx: effects of cimetidine. Ther Drug Monit (1987) 0.80
Gas chromatographic identification of thioridazine in plasma, and a method for routine assay of the drug. J Pharm Pharmacol (1969) 0.80
Nasal intubation in the foal. J Am Vet Med Assoc (1984) 0.80
Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine. Dis Nerv Syst (1973) 0.80
Drugs prohibited from extralabel use in food animals. J Am Vet Med Assoc (1999) 0.80
Renal ectopia in a dog. Aust Vet J (1974) 0.80
[Clinical guidelines - after the gathering comes the scattering?]. Dtsch Med Wochenschr (2010) 0.79
In vivo folate kinetics during chronic supplementation of human subjects with deuterium-labeled folic acid. J Nutr (1992) 0.79
Intravenous and oral pharmacokinetic evaluation of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of carbamazepine in the dog: comparison with commercially available tablets and suspensions. J Pharm Sci (1997) 0.79
Propofol in rabbits. 1. Determination of an induction dose. Lab Anim Sci (1993) 0.79
Drug distribution and effect. J R Coll Physicians Lond (1970) 0.79
Urinary excretion of chlorpromazine metabolites following single doses and in steady-state conditions. Res Commun Chem Pathol Pharmacol (1971) 0.78
Stability, human blood distribution and rat tissue localization of promazine and desmonomethylpromazine. Biopharm Drug Dispos (1990) 0.78
Late slow wave components of auditory evoked potentials: their cognitive significance and interaction. Electroencephalogr Clin Neurophysiol (1981) 0.78
Cimetidine interaction with amitriptyline. Eur J Clin Pharmacol (1985) 0.77
Extralabel use of ivermectin and moxidectin in food animals. J Am Vet Med Assoc (2000) 0.77
[Reference values of electrodiagnostic and laboratory studies in young Wallis Schwarzhals goats]. Tierarztl Prax (1996) 0.77
Contingent negative variation and slow waves in a short interstimulus interval go-nogo task situation. Ann N Y Acad Sci (1984) 0.77
Pharmacokinetics of nitroglycerin and its metabolites after administration of sustained-release tablets. Biopharm Drug Dispos (1992) 0.77
The Food Animal Residue Avoidance Databank (FARAD). Past, present and future. Vet Clin North Am Food Anim Pract (1999) 0.77
Distribution of cardiac output in anaesthetised horses. Res Vet Sci (1979) 0.77
Localization of basic drugs in the submaxillary gland. Biochem Pharmacol (1969) 0.77
Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients. Psychopharmacology (Berl) (1985) 0.77
Preparation and stability of intravenous solutions of sodium dichloroacetate (DCA). J Parenter Sci Technol (1992) 0.77
Event-related potentials as indicants of structural and functional damage in closed head injury. Prog Brain Res (1980) 0.76
Developments in management of the newborn foal in respiratory distress 2: Treatment. Equine Vet J (1984) 0.76
Developments in management of the newborn foal in respiratory distress 1: Evaluation. Equine Vet J (1984) 0.76
Animal model for investigation of fluphenazine kinetics after administration of long-acting esters. Biopharm Drug Dispos (1981) 0.76
Unwanted effects of fluphenazine enanthate and decanoate. Lancet (1979) 0.76
Tissue composition and halothane solubility in the horse. Br J Anaesth (1981) 0.76
Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin. Clin Pharmacol Ther (1984) 0.76
The strategy and value of neuroleptic drug monitoring. J Clin Psychopharmacol (1985) 0.76
Proceedings: A microsomal oxidase system in rat intestinal mucosa. Br J Pharmacol (1975) 0.75
Disposition of disodium cromoglycate administered in three particle sizes. Br J Clin Pharmacol (1975) 0.75
Plasma level studies in psychotropic evaluation. Br J Clin Pharmacol (1976) 0.75
Applications of cognitive ERPs in neurosurgical and neurological patients. Electroencephalogr Clin Neurophysiol Suppl (1986) 0.75
Changes in reaction time and drug plasma concentrations after nitrazepam and glutethimide. Br J Clin Pharmacol (1977) 0.75
Commentary: therapeutic monitoring of antipsychotic drugs. J Clin Psychopharmacol (1997) 0.75